Literature DB >> 19107423

FRET-based in vitro assays for the analysis of SUMO protease activities.

Michael H Tatham1, Ronald T Hay.   

Abstract

In humans cells three SUMO paralogues (SUMO-1, SUMO-2 and SUMO-3) and six SUMO specific proteases (SENP1-SENP3 and SENP5-SENP7) are expressed. Together the SUMO proteases perform three distinct functions. They: (1) process the immature pro-SUMO proteins into the active forms, (2) remove SUMO molecules conjugated to protein targets, and (3) depolymerise SUMO conjugated within polymeric chains. By regulating these processes the SENPs play a crucial role in regulating the sumoylation state of target proteins in cells, and therefore are academically and pharmacologically interesting enzymes. Gel-based techniques for SENP analysis are well established and can be used for many applications, but their laborious methodology makes them cumbersome tools for kinetic analysis or inhibitor screening. Therefore in vitro FRET-based assays have been developed to test the three major functions of the SENPs. These use fluorescent protein fusions of the SUMOs, and together facilitate high-throughput, real-time analysis of the three major SUMO protease activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107423     DOI: 10.1007/978-1-59745-566-4_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.

Authors:  Ryan N Gilbreth; Khue Truong; Ikenna Madu; Akiko Koide; John B Wojcik; Nan-Sheng Li; Joseph A Piccirilli; Yuan Chen; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 2.  Emerging roles of the SUMO pathway in development.

Authors:  Hilda Lomelí; Martha Vázquez
Journal:  Cell Mol Life Sci       Date:  2011-09-04       Impact factor: 9.261

3.  Assays for investigating deSUMOylation enzymes.

Authors:  Ikenna G Madu; Yuan Chen
Journal:  Curr Protoc Mol Biol       Date:  2012-07

4.  SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.

Authors:  Sindhu Rajan; Jacqueline Torres; Michael S Thompson; Louis H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-10       Impact factor: 4.310

5.  Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis.

Authors:  Sreenivas Gannavaram; Sonya Davey; Ines Lakhal-Naouar; Robert Duncan; Hira L Nakhasi
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20

6.  Identification and characterization of a new chemotype of noncovalent SENP inhibitors.

Authors:  Ikenna G Madu; Andrew T Namanja; Yang Su; Steven Wong; Yi-Jia Li; Yuan Chen
Journal:  ACS Chem Biol       Date:  2013-05-01       Impact factor: 5.100

7.  Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.

Authors:  Wei Yang; Liangli Wang; Wulf Paschen
Journal:  J Biomol Screen       Date:  2013-03-07

8.  Strategies to Identify Recognition Signals and Targets of SUMOylation.

Authors:  Elisa Da Silva-Ferrada; Fernando Lopitz-Otsoa; Valérie Lang; Manuel S Rodríguez; Rune Matthiesen
Journal:  Biochem Res Int       Date:  2012-07-01

9.  Targeting the SUMO pathway for neuroprotection in brain ischaemia.

Authors:  Wei Yang; Huaxin Sheng; Haichen Wang
Journal:  Stroke Vasc Neurol       Date:  2016-10-25

10.  Mps1 is SUMO-modified during the cell cycle.

Authors:  Agnese Restuccia; Feikun Yang; Changyan Chen; Lou Lu; Wei Dai
Journal:  Oncotarget       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.